Minerva Financial Statements From 2010 to 2025

Stocks USA . 
Stock . Minerva Neurosciences
NERV Stock  USD 1.97  0.08  3.90%   
Minerva Neurosciences financial statements provide useful quarterly and yearly information to potential Minerva Neurosciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Minerva Neurosciences financial statements helps investors assess Minerva Neurosciences' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Minerva Neurosciences' valuation are summarized below:
Gross Profit
-12.4 M
Market Capitalization
13.8 M
Enterprise Value Revenue
0.0345
Earnings Share
(0.45)
There are over one hundred nineteen available fundamental ratios for Minerva Neurosciences, which can be analyzed over time and compared to other ratios. All traders should should check Minerva Neurosciences' last-minute fundamental trends against the trends from 2010 to 2025 to make sure the company is sustainable. Enterprise Value is likely to climb to about 127.3 M in 2025, whereas Market Cap is likely to drop slightly above 43.7 M in 2025.
Check Minerva Neurosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Minerva Neurosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 33.8 K, Interest Expense of 10 M or Selling General Administrative of 12.6 B, as well as many indicators such as Price To Sales Ratio of 1.86, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Minerva financial statements analysis is a perfect complement when working with Minerva Neurosciences Valuation or Volatility modules.
  
Check out the analysis of Minerva Neurosciences Correlation against competitors.
For more information on how to buy Minerva Stock please use our How to Invest in Minerva Neurosciences guide.

Minerva Neurosciences Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets88 M65.4 M69.6 M
Slightly volatile
Total Current Liabilities4.4 M3.8 M3.5 M
Slightly volatile
Cash34.7 M47 M28.8 M
Slightly volatile
Cash And Short Term Investments51.4 M47.2 M41.2 M
Slightly volatile
Common Stock Total Equity3 K4.9 K2.9 K
Slightly volatile
Common Stock Shares Outstanding4.6 M7.5 M4.2 M
Slightly volatile
Liabilities And Stockholders Equity88 M65.4 M69.6 M
Slightly volatile
Other Current Assets1.2 M1.3 M81 M
Very volatile
Other Stockholder Equity264.5 M423.6 M225.2 M
Slightly volatile
Total Liabilities103.1 M98.2 M41.7 M
Slightly volatile
Total Current Assets52.9 M48.3 M42.4 M
Slightly volatile
Common Stock7648042 K
Pretty Stable
Short and Long Term Debt Total99 M94.3 M28.5 M
Slightly volatile
Property Plant And Equipment Net11.9 K12.5 K41.2 K
Pretty Stable
Current Deferred Revenue34 B47.4 B30.8 B
Slightly volatile
Accounts Payable1.5 M2.1 M1.3 M
Slightly volatile
Non Current Assets Total12.7 M13.4 M30.7 M
Slightly volatile
Other Assets1.3 M1.3 M13.2 M
Pretty Stable
Good Will15.7 M17.1 M13.3 M
Slightly volatile
Non Current Liabilities Total99 M94.3 M39.6 M
Slightly volatile
Short Term Debt121.5 K127.9 K2.6 B
Very volatile
Intangible Assets14.6 K15.3 K17.3 M
Slightly volatile
Property Plant Equipment36.8 K18.8 K24.9 K
Slightly volatile
Other Liabilities89 M84.8 M34.4 M
Slightly volatile
Capital Surpluse278.9 M388.1 M247.5 M
Slightly volatile
Deferred Long Term Liabilities1.5 M1.6 M11 M
Slightly volatile
Short and Long Term Debt3.2 M4.6 M3.1 M
Slightly volatile
Long Term Debt Total4.9 M3.5 M5.6 M
Slightly volatile
Net Working Capital46.9 M34.8 M84.5 M
Slightly volatile
Capital Stock5986293.1 K
Slightly volatile
Net Receivables2.5 M2.8 M3.1 M
Slightly volatile

Minerva Neurosciences Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization33.8 K35.6 K53 K
Slightly volatile
Selling General Administrative12.6 B12 B2.2 B
Slightly volatile
Other Operating Expenses38.3 M26.6 M30.4 M
Slightly volatile
Research Development26.4 M14.6 M20.6 M
Slightly volatile
Total Operating Expenses38.3 M26.6 M30.4 M
Slightly volatile
Non Operating Income Net Other102.7 K108.1 K307.4 K
Pretty Stable
Interest Income788.1 K1.3 M927.4 K
Very volatile
Reconciled Depreciation25.3 K26.7 K39.7 K
Slightly volatile
Extraordinary Items7.5 M8.5 M9.2 M
Slightly volatile
Selling And Marketing Expenses8.3 B9.4 B10.2 B
Slightly volatile

Minerva Neurosciences Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation2.2 M2.3 M4.6 M
Very volatile
Begin Period Cash Flow31 M41.6 M25.7 M
Slightly volatile
End Period Cash Flow34.8 M47.2 M28.8 M
Slightly volatile
Depreciation63.3 K35.6 K50.6 K
Pretty Stable

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.862.092.2769
Slightly volatile
Average Payables905.1 K1.2 M1.1 M
Slightly volatile
Stock Based Compensation To Revenue0.190.210.2312
Slightly volatile
Capex To Depreciation1.0E-41.0E-41.9058
Slightly volatile
EV To Sales1.371.541.6754
Slightly volatile
Payables Turnover0.01920.01540.0216
Slightly volatile
Sales General And Administrative To Revenue0.340.380.4124
Slightly volatile
Research And Ddevelopement To Revenue0.430.480.5252
Slightly volatile
Cash Per Share8.585.678.9389
Pretty Stable
Days Payables Outstanding30.4 K24.5 K26.6 K
Pretty Stable
Intangibles To Total Assets0.480.30.5254
Slightly volatile
Current Ratio9.7511.3210.5997
Slightly volatile
Graham Number23.2724.537.8743
Very volatile
Revenue Per Share6.467.267.9178
Slightly volatile
Interest Debt Per Share13.1212.494.0409
Slightly volatile
Debt To Assets1.361.30.4452
Slightly volatile
Days Of Payables Outstanding30.4 K24.5 K26.6 K
Pretty Stable
Pretax Profit Margin0.03770.04240.0462
Slightly volatile
Ebt Per Ebit0.861.171.0542
Slightly volatile
Operating Profit Margin0.03590.04040.044
Slightly volatile
Long Term Debt To Capitalization1.451.380.8395
Slightly volatile
Total Debt To Capitalization1.451.380.4719
Slightly volatile
Ebit Per Revenue0.03590.04040.044
Slightly volatile
Quick Ratio9.911.3210.746
Slightly volatile
Net Income Per E B T0.781.090.8959
Slightly volatile
Cash Ratio7.1911.028.0113
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.11.151.0131
Slightly volatile
Fixed Asset Turnover324364397
Slightly volatile
Debt Ratio1.361.30.4452
Slightly volatile
Price Sales Ratio1.862.092.2769
Slightly volatile
Asset Turnover0.570.640.7008
Slightly volatile
Net Profit Margin0.03770.04240.0462
Slightly volatile

Minerva Neurosciences Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap43.7 M46 M111.9 M
Pretty Stable

Minerva Fundamental Market Drivers

Forward Price Earnings11.2108
Cash And Short Term Investments41 M

Minerva Upcoming Events

13th of March 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
13th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Minerva Neurosciences Financial Statements

Minerva Neurosciences investors use historical fundamental indicators, such as Minerva Neurosciences' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Minerva Neurosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue47.4 B34 B
Cost Of Revenue35.6 K37 K
Stock Based Compensation To Revenue 0.21  0.19 
Sales General And Administrative To Revenue 0.38  0.34 
Research And Ddevelopement To Revenue 0.48  0.43 
Revenue Per Share 7.26  6.46 
Ebit Per Revenue 0.04  0.04 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Minerva Stock Analysis

When running Minerva Neurosciences' price analysis, check to measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY